Glenmede Investment Management, LP Dynavax Technologies Corp Transaction History
Glenmede Investment Management, LP
- $19.8 Trillion
- Q2 2025
A detailed history of Glenmede Investment Management, LP transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Glenmede Investment Management, LP holds 1,021,129 shares of DVAX stock, worth $10.8 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
1,021,129Holding current value
$10.8 Million% of portfolio
0.05%Shares
1 transactions
Others Institutions Holding DVAX
# of Institutions
294Shares Held
121MCall Options Held
294KPut Options Held
77.6K-
Black Rock Inc. New York, NY21.9MShares$232 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT17.8MShares$188 Million6.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.43MShares$89.2 Million0.0% of portfolio
-
State Street Corp Boston, MA6.4MShares$67.7 Million0.0% of portfolio
-
Chicago Capital, LLC5.23MShares$55.3 Million1.29% of portfolio
About DYNAVAX TECHNOLOGIES CORP
- Ticker DVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 126,474,000
- Market Cap $1.34B
- Description
- Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...